However, a limitation of our study is that we just checked the different expression levels of SHH, PTCH and SMO in different tumour gradings, and then we used analysis data from the GDC TCGA renal cell carcinoma (282 patients) to draw the survival curve. The gene discussed is SHH; the disease is neoplasm.